Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients

British Journal of Anaesthesia

Volumn 111, Issue 3, 2013, Pages 424-432

  Zanier, E R ^a   Zoerle, T ^b   Fiorini, M ^d   Longhi, L ^b   Cracco, L ^d   Bersano, A ^e   Branca, V ^c   Benedetti, M D ^d   De Simoni, M G ^a   Monaco, S ^d   Stocchetti, N ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

brain injury; cerebral vasospasm; H FABP; subarachnoid haemorrhage; protein

Indexed keywords

FATTY ACID BINDING PROTEIN; TAU PROTEIN;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN INJURY; BRAIN VASOSPASM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMATOSE PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DISABILITY; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; HEART; HUMAN; HYDROCEPHALUS; INJURY SEVERITY; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; LONG TERM CARE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERSISTENT VEGETATIVE STATE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN LOCALIZATION; SUBARACHNOID HEMORRHAGE;

EID: 84882758579     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet149     Document Type: Article

References (29)

1. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med 2006; 355: 928-39
2. Citerio G, Gaini SM, Tomei G, Stocchetti N. Management of 350 aneurysmal subarachnoid hemorrhages in 22 Italian neurosurgical centers. Intensive Care Med 2007; 33: 1580-6
3. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: The emerging revolution. Nat Clin Pract Neurol 2007; 3: 256-63
4. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006; 26: 1341-53
5. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: A review. Neurosurgery 2005; 56: 633-54
6. Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2007; 60: 658-67
7. Diringer MN. Subarachnoid hemorrhage: A multiple-organ system disease. Crit Care Med 2003; 31: 1884-5
8. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care 2008; 14: 135-41
9. Pelsers MM, Hanhoff T, Van der Voort D, et al. Brain-And hearttype fatty acid-binding proteins in the brain: Tissue distribution and clinical utility. Clin Chem 2004; 50: 1568-75
10. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005; 352: 15-35
11. Wunderlich MT, Hanhoff T, Goertler M, et al. Release of brain-Type and heart-Type fatty acid-binding proteins in serum after acute ischaemic stroke. J Neurol 2005; 252: 718-24
12. Glatz JF, van der Vusse GJ, Simoons ML, et al. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998; 272: 87-92
13. Ost M, Nylen K, Csajbok L, et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006; 67: 1600-4
14. Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-Term outcome in acute ischemic stroke. Clin Neurol Neurosurg 2006; 108: 558-63
15. Magnoni S, Esparza TJ, Conte V, et al. Tau elevations in the brain extracellular space correlate with reduced amyloid-b levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain 2012; 135: 1268-80
16. Zanier ER, Longhi L, Fiorini M, et al. Increased levels of CSF heart-Type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2008; 102: 339-43
17. Zanier ER, Brandi G, Peri G, et al. Cerebrospinal fluid Pentraxin 3 early after subarachnoid hemorrage is associated with vasospasm. Intensive Care Med 2011; 37: 302-9
18. Diringer MN, Bleck TP, Claude Hemphill J IIIrd, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference; Neurocritical Care Society. Neurocrit Care 2011; 15: 211-40
19. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: Report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 1988; 51: 1457
20. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1-9
21. Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: A review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma 1998; 15: 587-97
22. Naidech AM, Drescher J, Tamul P, Shaibani A, Batjer HH, Alberts MJ. Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006; 77: 1340-4
23. Bersano A, FioriniM, Allaria S, et al. Detection of CSF 14-3-3 protein in Guillain-Barre syndrome. Neurology 2006; 67: 2211-16
24. Turck N, Vutskits L, Sanchez-Pena P, et al. A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage. Intensive Care Med 2010; 36: 107-15
25. Steinacker P, Mollenhauer B, Bibl M, et al. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases. Neurosci Lett 2004; 370: 36-9
26. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J. Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke 2003; 34: E240-43
27. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993; 16: 460-5
28. Green AJ. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2002; 28: 427-40
29. Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KT. Delayed cerebral ischaemia after subarachnoid haemorrhage: Looking beyond vasospasm. Br J Anaesth 2012; 109: 315-29